High prevalence of occult left heart disease in scleroderma-pulmonary hypertension

Fox Benjamin D., Shimony Avi, Langleben David, Hirsch Andrew, Rudski Lawrence, Schlesinger Robert, Eisenberg Mark J., Joyal Dominique, Hudson Marie, Boutet Kim, Serban Alexandrina, Masetto Ariel, Baron Murray

Source: Eur Respir J 2013; 42: 1083-1091
Journal Issue: October
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fox Benjamin D., Shimony Avi, Langleben David, Hirsch Andrew, Rudski Lawrence, Schlesinger Robert, Eisenberg Mark J., Joyal Dominique, Hudson Marie, Boutet Kim, Serban Alexandrina, Masetto Ariel, Baron Murray. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J 2013; 42: 1083-1091

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Under pressure: pulmonary hypertension associated with left heart disease
Source: Eur Respir Rev 2015; 24: 665-673
Year: 2015



Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012


High prevalence of COPD among adults with heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019



How to define pulmonary hypertension due to left heart disease
Source: Eur Respir J 2016; 48: 553-555
Year: 2016


Pulmonary hypertension due to left heart disease
Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018
Year: 2019



Unexpected high prevalence of left ventricular cardiopathy in patients with COPD
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010



Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 422-430
Year: 2015



Pulmonary hypertension in left heart disease
Source: Eur Respir Rev 2012 21: 338-346
Year: 2012



Right heart failure in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Initial experience of sildenafil in patients with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006

Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease.
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
Source: Eur Respir Rev 2009; 18: 154-161
Year: 2009



Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD)
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



High prevalence of undiagnosed COPD in patients with cardiovascular disease
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009

Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?
Source: Eur Respir J 2013; 42: 888-890
Year: 2013


Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2011; 39: 112-118
Year: 2012



Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2012; 39: 112-118
Year: 2012



Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009